Immunoregulation by TLR-activated TIM-1+ ProB Cells in Transplantation
TLR 激活的 TIM-1 ProB 细胞在移植中的免疫调节
基本信息
- 批准号:10214480
- 负责人:
- 金额:$ 43.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-08-01 至 2023-07-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdultAllograft ToleranceAllograftingAntigensB cell differentiationB-LymphocytesBone MarrowCell CountCell LineageCellsCuesDependenceEngraftmentEnvironmentGenetic TranscriptionImmune responseImpairmentInflammatoryInterleukin-10Knockout MiceLeadLigationMS4A1 geneMaintenanceMediatingMethodsModelingMonoclonal AntibodiesNaturePathway interactionsPeripheralPhenotypePopulationProliferatingPropertyProtocols documentationReceptor SignalingRegulationRegulator GenesRegulatory T-LymphocyteRestRoleSignal PathwaySiteTherapeuticTimeTranslatingTransplantationTransplantation Tolerancebaseheart allograftimmunoregulationislet allograftknockout genemembermouse modelnano-stringsingle-cell RNA sequencingtranscriptome sequencing
项目摘要
Abstract (Project 2)
Rather than use passive transfer of well differentiated adult immunoregulatory cells as a means to create
transplant tolerance, we have discovered that a population CpG activated pro-B cells are extraordinarily potent,
far more potent on a per cell basis than Tregs and far easier to prepare. Transfer of only 40,000, but not
90,000, induces permanent engraftment and probably tolerance in MHC incompatible islet and cardiac allograft
mouse models. We have discovered that CpG induces expression TIM-1 a potential master switch for
expression of an immunoregulatory module in mature Bregs (see Project 1/ Kuchroo). We also learned that
ligation of TIM-1 by anti-TIM-1 mAb induces expression of IL-10, a member of the regulatory model discovered
by Kuchroo. The stepwise contributions of CpG and activation of the TIM-1 pathway are examined through
RNAseq and NanoString based analysis. To more precisely characterize the fate and phenotype, proliferative
and differentiation of CpG activated pro-B cells, lineage-tracking methods are utilized throughout. We know
that CpG activated pro-B cells proliferate and differentiate after transfer when introduced in optimal, not
excessive, cell number. Depending upon environmental cues CpG activated pro-B cells can differentiate into a
variety Bregs but CpG activated pro-B cells from RAG KO mice do not generate Bregs. In this project we will
analyze the cellular basis of tolerance believing that CpG activated B regs and their progeny create an
environment conducive to activation, expansion and retention of donor specific Tregs. The specific but
multifaceted requirements for B cell differentiation, including the nature of the niche impairing expansion and
differentiation of CpG-ProBs, in the acquisition of tolerance will be analyzed through use of a panel of carefully
selected gene knockout mice. The role of T and B regs in the induction and maintenance of tolerance will be
determined through time course protocols that selectively destroy Tregs or the mature progeny of CpG activate
pro cells. The diversity of CpG-ProB progeny and their expression of a regulatory module that is IL-10 inclusive
will be examined by single cell RNAseq of CpG-ProBs and their progeny at the transplant.
摘要(项目2)
而不是使用良好分化的成人免疫调节细胞的被动转移作为创造的一种手段
移植耐受性,我们发现种群CpG活化的Pro-B细胞非常有效,
比Tregs比Tregs更有效,并且更容易准备。仅转移40,000,但不转移
90,000,诱导永久性植入,可能在MHC不兼容的胰岛和心脏同种异体移植物中耐受性
鼠标模型。我们发现CPG诱导表达Tim-1一个潜在的主开关
成熟的布雷格人中免疫调节模块的表达(请参阅项目1/ kuchroo)。我们还了解到
通过抗TIM-1 MAB的结扎TIM-1诱导IL-10的表达,IL-10是发现的调节模型的成员
由川起。 CPG的逐步贡献和TIM-1途径的激活将通过
基于RNASEQ和纳米源分析。更精确地表征命运和表型,增殖性
和CpG激活的Pro-B细胞的分化,整个过程中都使用了谱系跟踪方法。我们知道
CpG激活的Pro-B细胞在最佳中引入时转移后扩散并分化,而不是
过多的细胞数。根据环境提示,CpG激活的pro-B细胞可以区分
Bregs,但CPG激活了来自RAG KO小鼠的Pro-B细胞,不会产生Bregs。在这个项目中,我们将
分析耐受性的细胞基础,认为CpG激活B regs及其后代会产生一个
有利于特定于供体特雷格的激活,扩展和保留的环境。具体但
B细胞分化的多方面要求,包括利基市场的性质损害扩展和
CPG探针的差异化,在获得耐受性时将通过使用一组小组进行分析
选定的基因敲除小鼠。 T和B规则在耐受性的诱导和维持中的作用将是
通过时间课程协议确定,这些方案有选择地破坏Treg或CpG的成熟后代激活
Pro细胞。 CpG-prob后代的多样性及其对IL-10包含的调节模块的表达
将通过CpG-probs的单细胞RNASEQ及其在移植时的后代进行检查。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAVID M ROTHSTEIN其他文献
DAVID M ROTHSTEIN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAVID M ROTHSTEIN', 18)}}的其他基金
Role of TIM Molecules in Regulatory and Inflammatory B cells in Allo andAutoimmunity
TIM 分子在同种异体和自身免疫中调节性和炎症性 B 细胞中的作用
- 批准号:
9751742 - 财政年份:2018
- 资助金额:
$ 43.75万 - 项目类别:
Inflammatory B cells defined by TIM-4 in the Alloimmune response
同种免疫反应中 TIM-4 定义的炎症 B 细胞
- 批准号:
10214481 - 财政年份:2018
- 资助金额:
$ 43.75万 - 项目类别:
Immunoregulation by TLR-activated TIM-1+ ProB Cells in Transplantation
TLR 激活的 TIM-1 ProB 细胞在移植中的免疫调节
- 批准号:
10455069 - 财政年份:2018
- 资助金额:
$ 43.75万 - 项目类别:
Role of TIM Molecules in Regulatory and Inflammatory B cells in Allo andAutoimmunity
TIM 分子在同种异体和自身免疫中调节性和炎症性 B 细胞中的作用
- 批准号:
10214475 - 财政年份:2018
- 资助金额:
$ 43.75万 - 项目类别:
Role of TIM Molecules in Regulatory and Inflammatory B cells in Allo andAutoimmunity
TIM 分子在同种异体和自身免疫中调节性和炎症性 B 细胞中的作用
- 批准号:
10455065 - 财政年份:2018
- 资助金额:
$ 43.75万 - 项目类别:
Inflammatory B cells defined by TIM-4 in the Alloimmune response
同种免疫反应中 TIM-4 定义的炎症 B 细胞
- 批准号:
10455071 - 财政年份:2018
- 资助金额:
$ 43.75万 - 项目类别:
Inflammatory B Cells Defined by TIM-4 in the Alloimmune Response
TIM-4 在同种免疫反应中定义的炎症 B 细胞
- 批准号:
9542016 - 财政年份:2017
- 资助金额:
$ 43.75万 - 项目类别:
In Vivo Detection And Mechanisms Of Regulatory B Cell Function In Transplantation
移植中调节性 B 细胞功能的体内检测和机制
- 批准号:
9197259 - 财政年份:2015
- 资助金额:
$ 43.75万 - 项目类别:
相似国自然基金
成人型弥漫性胶质瘤患者语言功能可塑性研究
- 批准号:82303926
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
- 批准号:82302160
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
成人免疫性血小板减少症(ITP)中血小板因子4(PF4)通过调节CD4+T淋巴细胞糖酵解水平影响Th17/Treg平衡的病理机制研究
- 批准号:82370133
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
SMC4/FoxO3a介导的CD38+HLA-DR+CD8+T细胞增殖在成人斯蒂尔病MAS发病中的作用研究
- 批准号:82302025
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
融合多源异构数据应用深度学习预测成人肺部感染病原体研究
- 批准号:82302311
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Immunoregulation by TLR-activated TIM-1+ ProB Cells in Transplantation
TLR 激活的 TIM-1 ProB 细胞在移植中的免疫调节
- 批准号:
10455069 - 财政年份:2018
- 资助金额:
$ 43.75万 - 项目类别:
Induction of allogeneic tolerance with bioengineered thymus organoids
用生物工程胸腺类器官诱导同种异体耐受
- 批准号:
9203600 - 财政年份:2016
- 资助金额:
$ 43.75万 - 项目类别:
Induction of allogeneic tolerance with bioengineered thymus organoids
用生物工程胸腺类器官诱导同种异体耐受
- 批准号:
9082794 - 财政年份:2016
- 资助金额:
$ 43.75万 - 项目类别:
Immunosuppression Withdrawal for Stable Pediatric Liver Transplant Recipients
稳定儿童肝移植受者的免疫抑制撤药
- 批准号:
8054698 - 财政年份:2010
- 资助金额:
$ 43.75万 - 项目类别:
Immunosuppression Withdrawal for Stable Pediatric Liver Transplant Recipients
稳定儿童肝移植受者的免疫抑制撤药
- 批准号:
8334913 - 财政年份:2009
- 资助金额:
$ 43.75万 - 项目类别: